Leading Cloud Genomics Company DNAnexus Partners With SolveBio to Make Genomic Data More Actionable for Pharmaceutical and Diagnostics Industry

MOUNTAIN VIEW, Calif. & NEW YORK–(BUSINESS WIRE)– DNAnexus
Inc., the leader in cloud-based genome informatics and data
management, today announced a partnership with SolveBio,
the global provider of Genomics Intelligence, to integrate the two
platforms and provide seamless access to SolveBio’s curated data and
analysis services. Researchers globally will have the ability to move
quickly from genomic data analysis to interpretation, freeing up time to
focus on generating uniquely actionable biological insights.

DNAnexus combines expertise in cloud computing and bioinformatics to
provide the global network for organizations that are pursuing
genomic-based approaches to health, in the clinic and in the research
lab. DNAnexus provides pharmaceutical and biotech companies, global
diagnostic test providers, genome centers, and sequencing service
providers the infrastructure and scientific support to solve today’s
genomic challenges faster and more effectively than ever before.

“Both DNAnexus and SolveBio make genomic data more accessible, easier to
analyze, and more actionable,” said Richard Daly, CEO of DNAnexus. “We
view the integration of DNAnexus’ and SolveBio’s complementary product
offerings as a way help to remove barriers to genomic insight and
provide better solutions to enterprises globally.”

SolveBio gathers, secures, and monitors real-time, critical Genomics
Intelligence for the pharmaceutical and global diagnostic markets.
Access to the latest discoveries and expert assessments in genomics
guides key investment decisions in R&D and treatment plans in the
clinic. SolveBio turns evaluating and using internal and external
insights and information into a standardized task-oriented process for
scientists, clinicians, and directors. Integrating with genomic analysis
companies allows enterprises leveraging genomics to bring Genomics
Intelligence into any workflow or pipeline in a standardized process.

“Our passion is to help scientists make sense of complexity and to use
that intelligence to drive issues around human health,” said Mark
Kaganovich, CEO of SolveBio. “Our goals are aligned with those of
DNAnexus and an integration between our solutions makes a great deal of
sense. We look forward to our collective customers being able to
seamlessly integrate their analyses with the contextual information that
SolveBio provides.”

About DNAnexus

DNAnexus combines expertise in cloud computing and bioinformatics to
create the global network for genomics, operating in North America,
Europe, Asia-Pacific (including China), South America, and Africa. The
secure, scalable, and collaborative cloud-based DNAnexus Platform helps
thousands of researchers across a spectrum of industries –
biopharmaceutical, bioagricultural, sequencing services, clinical
diagnostics, government, and research consortia – accelerate their
genomics programs globally. For more information, please visit www.dnanexus.com
or follow the company @DNAnexus.

About SolveBio

SolveBio deploys technology and on-demand expertise to drive precision
medicine. SolveBio’s network of genomics specialists leverages the
Genome Intelligence Platform to extract and evaluate complex biomedical
data for diagnostic labs, academic centers, and biopharma. By connecting
specialists to real-time data, SolveBio helps life science enterprises
functionally assess variants and genes with clinical precision. For more
information, please visit http://www.solvebio.com
or follow the company @Solve.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160421005311/en/